Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-087657
Filing Date
2025-06-17
Accepted
2025-06-17 21:40:29
Documents
2
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 19048
2 EX-24 cai-ex24.htm EX-24 5959
  Complete submission text file 0000950170-25-087657.txt   27021
Mailing Address C/O SIXTH STREET PARTNERS, LLC 345 CALIFORNIA STREET, SUITE 2600 SAN FRANCISCO CA 94104
Business Address
Waxman Alan (Reporting) CIK: 0001515132 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42706 | Film No.: 251055033

Mailing Address 301 COMMERCE STREET FORT WORTH TX 76102
Business Address 301 COMMERCE STREET FORT WORTH TX 76102 (817) 871-4000
TSSP Sub-Fund HoldCo LLC (Reporting) CIK: 0001677508 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42706 | Film No.: 251055034

Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Issuer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)